Table 1.
Baseline characteristics of patients (n=126)
| Variables | Values |
|---|---|
| Demographic variables | |
| Age, years | 58 (34–85) |
| Male sex, n | 101 (80.2) |
| Viral etiology, n | 90 (71.4) |
| ECOG, 0–1/2, n | 120 (95.2)/6 (4.8) |
| Child-Pugh class, A/B, n | 96 (76.2)/30 (23.8) |
| Previous treatment history, n | 92 (73.0) |
| Tumor variables | |
| Tumor size, cm | 7.8 (2.0–18.0) |
| Multiple tumors, ≥4 | 57 (45.2) |
| Infiltrative type | 50 (39.7) |
| Portal vein invasion | 48 (38.1) |
| Presence of EHS and/or RNI | 87 (69.0) |
| Laboratory variables | |
| Alanine aminotransferase, IU/dL | 28 (3–433) |
| Prothrombin time, INR | 1.1 (0.9–2.2) |
| Total bilirubin, mg/dL | 0.8 (0.3–3.6) |
| Serum albumin, mg/dL | 3.9 (2.6–5.2) |
| Tumor markers | |
| AFP, mg/dL | 291.6 (22–120,000) |
| PIVKA-II, mAU/mL | 491.5 (50–75,000) |
Note: Values are expressed as median (range) or number (%).
Abbreviations: ECOG, Eastern Cooperative Oncology Group; EHS, extrahepatic spread; RNI, regional nodal involvement; INR, international normalized ratio; AFP, α-fetoprotein; PIVKA-II, protein induced by vitamin K absence-II.